Leerink Partnrs Issues Positive Estimate for ARDT Earnings

Ardent Health Partners, LLC (NYSE:ARDT) – Stock analysts at Leerink Partnrs upped their Q4 2025 earnings per share estimates for shares of Ardent Health Partners in a research note issued on Tuesday, April 1st. Leerink Partnrs analyst W. Mayo now forecasts that the company will post earnings of $0.68 per share for the quarter, up from their previous estimate of $0.61. The consensus estimate for Ardent Health Partners’ current full-year earnings is $1.23 per share. Leerink Partnrs also issued estimates for Ardent Health Partners’ Q1 2026 earnings at $0.38 EPS, Q2 2026 earnings at $0.57 EPS, Q3 2026 earnings at $0.46 EPS and Q4 2026 earnings at $0.66 EPS.

Ardent Health Partners (NYSE:ARDT) last released its quarterly earnings results on Wednesday, February 26th. The company reported $0.81 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.50 by $0.31. The firm had revenue of $1.61 billion for the quarter, compared to analyst estimates of $1.48 billion.

Other research analysts have also issued reports about the company. Stephens reissued an “overweight” rating and set a $22.00 price target on shares of Ardent Health Partners in a research report on Tuesday. JPMorgan Chase & Co. reiterated a “neutral” rating and issued a $20.00 target price on shares of Ardent Health Partners in a report on Tuesday, December 17th. Morgan Stanley decreased their price target on shares of Ardent Health Partners from $23.50 to $22.00 and set an “overweight” rating for the company in a report on Tuesday, January 21st. Truist Financial dropped their price objective on shares of Ardent Health Partners from $22.00 to $21.00 and set a “buy” rating on the stock in a research note on Monday, January 6th. Finally, Royal Bank of Canada decreased their target price on shares of Ardent Health Partners from $23.00 to $21.00 and set an “outperform” rating for the company in a research note on Tuesday, March 4th. Two analysts have rated the stock with a hold rating, eight have assigned a buy rating and two have issued a strong buy rating to the company. According to MarketBeat, the stock currently has an average rating of “Buy” and a consensus price target of $21.18.

Ardent Health Partners Price Performance

Shares of NYSE:ARDT opened at $12.22 on Thursday. The company’s fifty day moving average is $14.25 and its two-hundred day moving average is $16.07. The company has a debt-to-equity ratio of 0.78, a current ratio of 1.91 and a quick ratio of 1.78. Ardent Health Partners has a 12-month low of $12.13 and a 12-month high of $20.72.

Hedge Funds Weigh In On Ardent Health Partners

Several institutional investors have recently bought and sold shares of the stock. Point72 Asia Singapore Pte. Ltd. bought a new position in shares of Ardent Health Partners in the fourth quarter valued at approximately $27,000. US Bancorp DE acquired a new position in Ardent Health Partners in the 4th quarter valued at $31,000. R Squared Ltd bought a new position in Ardent Health Partners in the 4th quarter worth $37,000. BNP Paribas Financial Markets acquired a new position in Ardent Health Partners during the 3rd quarter worth $42,000. Finally, New York State Common Retirement Fund bought a new stake in Ardent Health Partners during the fourth quarter valued at about $48,000.

About Ardent Health Partners

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.